NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS
No Result
View All Result
NORTH AMERICAN BUSINESS
No Result
View All Result
Home ALL Healthcare

Tech solutions to support advanced prostate cancer diagnoses

by Ed Johnson
July 7, 2021
A A

07/06/2021

In December 2020, the FDA announced that a new radioactive diagnostic agent, Gallium 68 (Ga-68) PSMA-11, could be prescribed and administered to patients with suspected prostate cancer metastasis and suspected prostate cancer recurrence.

Ga-68 is being used in nearly 400 investigational trials for both prostate and other types of cancer, according to the journal Applied Radiology. Based on the outcomes of these trials, the demand for Ga-68 is expected to grow significantly.

Cardinal Health and our robust network of radiopharmacies are poised to meet the demand. We have more than 130 nuclear pharmacies across the country; currently, more than 110 of them are licensed to possess Ga-68, and we expect all 130 to be licensed in the coming months. “We will be able to make these essential radiopharmaceuticals available to healthcare providers and the patients they serve across the country,” said Luke Augustine, vice president of business development for Cardinal Health Nuclear & Precision Health Solutions.

Managing the half-life of Ga-68 
Any Ga-68 supply chain strategy must account for the radioactive isotope’s relatively short half-life, Augustine explained. (In nuclear medicine, a half-life is the time it takes for half of the radioactive atoms to decay. The half-life of Ga-68 is about 68 minutes, which means that it must be delivered to providers quickly once it has been prepared.)

Our Nuclear & Precision Health Solutions team manages this half-life with proprietary technologies like AccutracTM, which tracks doses as they move from our nuclear pharmacies to sites of care. (Accutrac has a greater than 99% on-time delivery record.) This technology also documents the chain of custody of patient doses and flags any potential delays in delivery, allowing us to monitor all doses and ensure they are delivered as rapidly as possible.

In addition, providers can use NuctracTM, our cloud-native nuclear medicine department management system, to see exactly when their patient doses will arrive, so they can manage their schedule accordingly.

Partnering with Ga-68 generator manufacturers
At the time of FDA approval of the first Ga-68 radiopharmaceutical in 2016, the Germanium-68 (Ge-68) generators needed to prepare Ga-68 radiopharmaceuticals were scarce, which triggered concerns among health systems about supply. (At first, in fact, the entire world relied on a single Ge-68/Ga-68 generator.)

Today, however, there are three approved manufacturers of Ge-68/Ga-68 generators. Cardinal Health is working with one of the manufacturers, Belgium-based IRE, to distribute generators across the United States. The generators from IRE, called Galli Eo®, feature a small, tabletop design and produce Ga-68 quickly. They can be set up in a nuclear pharmacy to prepare and dispense patient-ready unit doses for just-in-time delivery to sites of care.

“With the addition of multiple Ga-68 supply sources, and a continued expansion of FDA-approved Ga-68 diagnostics, Ga-68 shortages are a thing of the past,” Augustine said.

“Healthcare systems in cities and rural areas will have access to this important diagnostic technology.”

Tags: < New Launches
ShareTweetShareSend

Related Industries

Healthcare

Bayer Announces Changes to U.S. Country Leadership Team

June 9, 2023
Healthcare

Cardinal Health announces the merger of its Outcomes™ business into Transaction Data Systems and related partnership

June 6, 2023
Healthcare

Medtronic names Ken Washington new Chief Technology and Innovation Officer

June 2, 2023
Healthcare

BD Names Laura Boros President of Pharmaceutical Systems

June 2, 2023
Healthcare

Medtronic to acquire wearable insulin patch maker EOFlow

May 26, 2023
Healthcare

Thermo Fisher Scientific Releases 2022 Corporate Social Responsibility Report

May 18, 2023

Cardinal Health Canada to open new distribution center in Ontario

May 11, 2023

...

Amgen Responds to Ftc Action RE: Proposed Acquisition Of Horizon Therapeutics

May 17, 2023

...

DuPont Earns Great Place to Work Certification™

May 18, 2023

...

Blackstone Completes Acquisition of Majority Stake of Copeland, Formerly Emerson Climate Technologies

June 1, 2023

...

BD Names Laura Boros President of Pharmaceutical Systems

June 2, 2023

...

Honeywell Completes First Flight Managed By Honeywell Anthem Integrated Flight Deck

May 13, 2023

...

KKR to Acquire Leading Testing and Measurement Instrument Provider Industrial Physics from Union Park Capital

May 12, 2023

...

Blackstone Acquires International Gemological Institute (IGI)

May 22, 2023

...

IBM’s The Weather Company Continues to Be the World’s Most Accurate Forecaster Overall, Despite Growing Competition and Amid Weather’s Increased Impact

May 16, 2023

...

NORTH AMERICAN BUSINESS (www.na-biz.com) is a leading source of business and corporate news, information, industry trends, market updates and insights across a broad spectrum of industries in North America and worldwide.

MENU

  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

CONTACT US

EDITORIAL:     editor#na-biz.com

PARTNERSHIP:     biz#na-biz.com

HUMAN RESOURCE:     hr#na-biz.com

* (replace # with @)

  • Official Site

Copyright © NA-BIZ.COM All rights reserved.

No Result
View All Result
  • HOME
  • SUSTAINABILITY
  • INVEST
  • MARKET
  • PARTNERSHIP
  • INNOVATION
  • PEOPLE
  • INSIGHTS

Copyright © NA-BIZ.COM All rights reserved.